坦桑尼亚HPV疫苗接种实施的促进因素与障碍:2018-2023年国家、次国家及社区利益相关者视角的混合方法研究
该研究于2024年4月在坦桑尼亚4个地区对18名国家和次国家免疫工作人员及80名卫生工作者、教师和社区影响者进行混合方法访谈,评估HPV疫苗接种项目实施中的障碍、促进因素与建议。政治支持、质量改进循环和与现有系统整合促进项目成功;资金缺口、人员短缺、卫生与教育部门协调不佳及社区意识低是障碍。建议增加政府资金、加强跨部门合作、培训利益相关者并扩大传播渠道。
要点
- 政治支持、质量改进循环和系统整合是坦桑尼亚HPV疫苗接种项目成功的促进因素。
- 资金缺口、人员短缺、卫生与教育部门协调不佳及社区意识低是主要障碍。
- 利益相关者建议增加政府资金、加强跨部门合作、培训并扩大传播渠道。
核心结论
- 坦桑尼亚的经验为相似背景下的HPV疫苗接种提供借鉴;通过增加资金、改善协调和加强社区参与解决关键障碍,可改善坦桑尼亚及其他地区的HPV疫苗接种实施,助力全球消除宫颈癌。
研究设计与样本
- 2024年4月进行的并发混合方法评估,访谈国家和次国家免疫工作人员18名及卫生工作者、教师和社区影响者80名。
- 根据2020-2022年第一剂HPV覆盖率及城乡分布等标准,目的性选取31个地区中的4个地区,每个地区从设施列表随机选取2家卫生设施,并从每家设施服务区选取2所接种疫苗的学校。
- 定量数据使用STATA v.18进行描述性分析,定性数据使用ATLAS.ti Web(v19.3.1)分析。
主要发现
- 政治支持、质量改进循环和与现有系统整合被认定为促进项目成功的因素。
- 资金缺口和人员短缺——尤其在HPV疫苗接种覆盖率低的地区——是报告的障碍之一,同时存在卫生与教育部门协调不佳和社区意识低。
- 建议包括增加政府资金、加强跨部门合作、培训利益相关者以及扩大传播渠道以改善需求和应对疫苗犹豫。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cervical cancer is the fourth most common cancer among women globally, disproportionately affecting those in low- and middle-income countries (LMICs). In 2020, World Health Organization (WHO) Member States endorsed the 2030 Global Strategy toward Elimination of Cervical Cancer, recommending expanded access to human papillomavirus (HPV) vaccination. However, gaps remain in understanding how LMICs can sustain high HPV vaccine coverage. Tanzania, an early adopter among LMICs, introduced HPV vaccination into the national immunization schedule for 14-year-old girls in 2018 and achieved >90 % two-dose coverage by 2023. This study evaluated HPV vaccine program implementation in Tanzania, capturing stakeholder perspectives on barriers, facilitators, and recommendations. METHODS: Stakeholders were interviewed in April 2024 in a concurrent mixed-methods evaluation. Participants included national and subnational immunization staff (n = 18), and health workers, teachers, and community influencers (n = 80). Four of 31 regions were purposively selected based on criteria including first-dose HPV coverage (2020-2022) and urban/rural distribution. Two health facilities were randomly selected from a list of facilities in each region, along with two schools administering the vaccine from each facility's catchment area. Quantitative data were analyzed descriptively in STATA v.18, and qualitative data analyzed in ATLAS.ti Web (v19.3.1). RESULTS: Political support, quality improvement cycles, and integration with existing systems were identified as contributing to program success. Funding gaps and staff shortages-particularly in regions with low HPV vaccination coverage-were among the reported barriers, along with poor coordination between health and education sectors and low community awareness. Recommendations included increasing government funding, strengthening cross-sector collaboration, training stakeholders, and expanding dissemination channels to improve demand and address vaccine hesitancy. CONCLUSIONS: Tanzania's experience offers lessons for HPV vaccination in similar contexts. Addressing key barriers through increased funding, improved coordination, and enhanced community engagement could improve HPV vaccination implementation in Tanzania and elsewhere, contributing to global cervical cancer elimination.
引用
- Carlton JG, Pamba D, Ryan N, et al. Facilitators and barriers to implementation of HPV vaccination in Tanzania: a mixed-methods study exploring perspectives from national, subnational, and community stakeholders, 2018-2023. Vaccine. 2025. PMID: 40752248. doi:10.1016/j.vaccine.2025.127560
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。